\-\ Texto\\:\\ \ \(0\)\
\-\ upper\\ extremity\\ weakness\\.\ \(6\)\
\-\ elevated\\ oligoclonal\\ bands\\ in\\ csf\\.\ \(0\)\
\-\ steroids\\ and\\ various\\ other\\ medications\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ supratentorial\\ foci\\ of\\ elevated\\ t2\\ signal\\ both\\ adjacent\\ to\\ ventricle\\ and\\ in\\ the\\ peripheral\\ white\\ matter\\.\ \(0\)\
\-\ \\â\\€\\¢\\ enhancement\\ of\\ right\\ parietal\\ lesion\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ atrophy\ \(0\)\
\-\ \\â\\€\\¢\\ abnormal\\ signal\\ in\\ cervical\\ cord\\ with\\ enhancement\ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ pml\ \(0\)\
\-\ adem\ \(8\)\
\-\ sspe\ \(0\)\
\-\ transverse\\ myelitis\ \(14\)\
\-\ 42\\ year\\ old\\ woman\\ with\\ long\\ history\\ of\\ multiple\\ sclerosis\ \(0\)\
\-\ the\\ enhancing\\ plaques\\ in\\ the\\ cervical\\ spinal\\ cord\\ and\\ right\\ occipital\\ region\\ indicate\\ areas\\ of\\ acute\\ \\(active\\)\\ plaque\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sclerosis\\:\\ 0\\.1011862164865828\ \(0\)\
\-\ sspe\\:\\ 0\\.0968738288347967\ \(0\)\
\-\ multiple\\:\\ 0\\.07911235180128655\ \(0\)\
\-\ pml\\:\\ 0\\.07718416433778509\ \(0\)\
\-\ oligoclonal\\:\\ 0\\.07157069594475222\ \(0\)\
\-\ cord\\:\\ 0\\.0713664597847341\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06887975171850057\ \(0\)\
\-\ cervical\\:\\ 0\\.06824376717783799\ \(0\)\
\-\ myelitis\\:\\ 0\\.06573961626275036\ \(0\)\
\-\ elevated\\:\\ 0\\.0637212387111882\ \(0\)\
\-\ supratentorial\\:\\ 0\\.06065584129628758\ \(0\)\
\-\ adem\\:\\ 0\\.05661490964655882\ \(0\)\
\-\ plaque\\:\\ 0\\.05661490964655882\ \(0\)\
\-\ bands\\:\\ 0\\.0560653445852988\ \(0\)\
\-\ indicate\\:\\ 0\\.05324424736719096\ \(0\)\
\-\ plaques\\:\\ 0\\.052444694023428\ \(0\)\
\-\ various\\:\\ 0\\.05188103144774064\ \(0\)\
\-\ enhancement\\:\\ 0\\.05034041244226453\ \(0\)\
\-\ signal\\:\\ 0\\.049518117148852285\ \(0\)\
\-\ atrophy\\:\\ 0\\.04844834260112357\ \(0\)\
\-\ 42\\:\\ 0\\.047548154442135816\ \(0\)\
\-\ steroids\\:\\ 0\\.04417283382823909\ \(0\)\
\-\ occipital\\:\\ 0\\.04381543611718899\ \(0\)\
\-\ medications\\:\\ 0\\.04188540789034109\ \(0\)\
\-\ foci\\:\\ 0\\.04030795546322028\ \(0\)\
\-\ parietal\\:\\ 0\\.04011793901146137\ \(0\)\
\-\ csf\\:\\ 0\\.03921422364621992\ \(0\)\
\-\ transverse\\:\\ 0\\.0376532603752747\ \(0\)\
\-\ matter\\:\\ 0\\.03697230736704173\ \(0\)\
\-\ active\\:\\ 0\\.03585229493455913\ \(0\)\
\-\ ventricle\\:\\ 0\\.035191102390971736\ \(0\)\
\-\ weakness\\:\\ 0\\.034874850033278955\ \(0\)\
\-\ extremity\\:\\ 0\\.03434240625980701\ \(0\)\
\-\ peripheral\\:\\ 0\\.03397728925290239\ \(0\)\
\-\ spinal\\:\\ 0\\.033623914399775676\ \(0\)\
\-\ cerebral\\:\\ 0\\.032532379140264515\ \(0\)\
\-\ long\\:\\ 0\\.032376060558601365\ \(0\)\
\-\ areas\\:\\ 0\\.03159722166204469\ \(0\)\
\-\ white\\:\\ 0\\.031144002337494703\ \(0\)\
\-\ adjacent\\:\\ 0\\.02969050817729964\ \(0\)\
\-\ enhancing\\:\\ 0\\.029450038822909443\ \(0\)\
\-\ abnormal\\:\\ 0\\.02678123341005397\ \(0\)\
\-\ t2\\:\\ 0\\.026577898557696177\ \(0\)\
\-\ region\\:\\ 0\\.026523090409223217\ \(0\)\
\-\ both\\:\\ 0\\.023980219677869466\ \(0\)\
\-\ acute\\:\\ 0\\.02318548713303841\ \(0\)\
\-\ upper\\:\\ 0\\.02266022533372218\ \(0\)\
\-\ woman\\:\\ 0\\.021691241181196773\ \(0\)\
\-\ other\\:\\ 0\\.021644379656070866\ \(0\)\
\-\ right\\:\\ 0\\.019816081518910258\ \(0\)\
\-\ lesion\\:\\ 0\\.0191269805054995\ \(0\)\
\-\ in\\:\\ 0\\.018522955171000218\ \(0\)\
\-\ history\\:\\ 0\\.012969390524253666\ \(0\)\
\-\ year\\:\\ 0\\.01050665131069137\ \(0\)\
\-\ old\\:\\ 0\\.009614665899585217\ \(0\)\
\-\ \\(\\:\\ 0\\.007938040947734731\ \(0\)\
\-\ \\)\\:\\ 0\\.00784107353970665\ \(0\)\
\-\ and\\:\\ 0\\.0059343628263368725\ \(0\)\
\-\ of\\:\\ 0\\.005121046188922568\ \(0\)\
\-\ to\\:\\ 0\\.004693056136736113\ \(0\)\
\-\ the\\:\\ 0\\.004557668726493158\ \(0\)\
\-\ with\\:\\ 0\\.0025715203536239503\ \(0\)\
\-\ \\.\\:\\ 0\\.0015604191691141222\ \(0\)\
